|
| Status |
Public on Feb 13, 2019 |
| Title |
Next Generation Sequencing Facilitates Quantitative Analysis of ischemic postconditioning (IPO) to attenuate hepatic ischemia-reperfusion injury in mice |
| Organism |
Mus musculus |
| Experiment type |
Expression profiling by high throughput sequencing
|
| Summary |
This is the first study to investigate mRNA expression profiling in regard to hepatic I/R and IPO by next-generation RNA-Seq. Our results may provide an experimental basis for elucidating the underlying mechanism of IPO and reveal candidate biomarkers with which to assess hepatic I/R injury
|
| |
|
| Overall design |
liver mRNA profiles of sham, I/R and IPO mice were generated by next-generation sequencing, in triplicate, using Illumina HiSeq 4000.
|
| |
|
| Contributor(s) |
Ye Q, Zhang P |
| Citation(s) |
30745817 |
| |
| Submission date |
Jul 13, 2018 |
| Last update date |
Mar 19, 2019 |
| Contact name |
Pengpeng Zhang |
| E-mail(s) |
yqf_china@126.com
|
| Phone |
15116256469
|
| Organization name |
The Third Xiangya Hospital of Central South University
|
| Street address |
No.138 Tongzipo Road
|
| City |
Changsha |
| State/province |
Hunan |
| ZIP/Postal code |
410013 |
| Country |
China |
| |
|
| Platforms (1) |
| GPL21103 |
Illumina HiSeq 4000 (Mus musculus) |
|
| Samples (9)
|
|
| Relations |
| BioProject |
PRJNA481000 |
| SRA |
SRP153358 |
Less...
More...